Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
Julia Lai‐Kwon, Andrisha–Jade Inderjeeth, Karolina Lisy, Shahneen Sandhu, Claudia Rutherford, Michael Jefford
Topics & Concepts
MedicinePembrolizumabPsycINFOQuality of life (healthcare)MEDLINEMeta-analysisOncologyInternal medicineRandomized controlled trialAdjuvant therapySystematic reviewMelanomaDabrafenibCancerImmunotherapyMetastatic melanomaNursingVemurafenibLawPolitical scienceCancer researchCutaneous Melanoma Detection and ManagementCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways